EDMONTON, Oct. 2 /CNW/ - Quest PharmaTech Inc. (“Quest” or the “Company”) is pleased to announce that it has come to an agreement with the holders of the $1,000,000 convertible debenture to postpone the maturity date by one year to September 22, 2007. Under the new agreement, the interest rate has changed from 8% to 9% per annum and the debenture conversion price has changed from $0.45 to $0.25 per common share.
